Healthcare

Osprey Medical Inc. (ASX:OSP)

Industry Group : Health Care Equipment & Services | Industry Group Name : Health Care Equipment & Supplies

Market Price : AUD 0.7550.005 (0.667%)

(as on 2021-11-30 20:56:58 AEDT)

Market Cap : AUD 38.744 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
0.75 0.75 0.755 0.750L 0.775 H 0.011L 101.000 H
Last Trade 0.755
Change% 0.6667
52 W H/L 101.000/0.011
EBITDA -12.44 M
NPAT After Abnormal Items -17.37 M
Equity 5.706 M
ROE% -304.40%
Total Liabilities 4.536 M
Total Revenue 2.192 M
Cash and Cash Equivalents 7.514 M

Stock Information

Share price 0.755
Market Cap 38.744 M
Price/Gross Cash Flow -3.04
Dividend Yield Excluding Special 0.00%
Ending Shares 16.233 M
52-Week Range 101.000-0.011
P/E ratio 2.427
Sector P/E --
EPS -1.47
EV/EBITDA --
Net Profit Margin (%) -800.19%
Gross Cash Flows Per Share -0.99
Net Gearing -93.14%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 41.200
Net Tangible Asset (NTA) 0.00
Sales Per Share 0.18
Book Value Per Share 0.00

Announcements

Heading Date/Time
Notification regarding unquoted securities - OSP  03/11/2021 2:09PM
DyeVert highlighted by leading experts for reduction of AKI  28/10/2021 8:59AM
Appendix 4C  20/10/2021 8:26AM
Notification regarding unquoted securities - OSP  14/10/2021 9:12AM
Quarterly Results and Investor Conference Call Notification  13/10/2021 8:23AM
Osprey Technology Featured at Italian Cardiology Meeting  11/10/2021 9:05AM
Appendix 3Y  30/09/2021 9:52AM
Appendix 3Y  30/09/2021 9:51AM
Notification regarding unquoted securities - OSP  30/09/2021 9:50AM
Reverse Stock Split and Dispatch of Holding Statements  23/09/2021 9:57AM
GE ramps up promotion of Osprey DyeVert System across Europe  23/09/2021 9:06AM
Results of Special Meeting of Stockholders  03/09/2021 1:15PM
Update - Consolidation/Split - OSP  03/09/2021 1:13PM
Notification of cessation of securities - OSP  01/09/2021 8:33AM
Consolidation/Split - OSP  20/08/2021 8:51AM
Notice of Special Meeting of Stockholders  20/08/2021 8:50AM
Global expansion strategy progress strengthens revenues  17/08/2021 8:38AM
Appendix 4D Half Year Report & Accounts  17/08/2021 8:32AM
Appendix 3X  12/08/2021 8:55AM
Martin Emerson appointed to Osprey Medical Board  12/08/2021 8:54AM
Notification of cessation of securities - OSP  02/08/2021 9:17AM
Appendix 4C  29/07/2021 8:22AM
Quarterly Results and Investor Conference Call Notification  22/07/2021 8:54AM
Canadian Expansion and exclusive GE distribution agreement  20/07/2021 9:14AM
Notification regarding unquoted securities - OSP  12/07/2021 9:24AM
Appendix 3Y  12/07/2021 8:59AM
Appendix 3Y  12/07/2021 8:56AM
Appendix 3Y  12/07/2021 8:56AM
Appendix 3X  02/07/2021 9:15AM

Similar Companies

Related Articles

About Company

Osprey Medical Inc (ASX: OSP) is under the Health Care sector and is a commercial stage company. The company is into a medical device technology used for the prevention of Contrast Induced Nephropathy (CIN), and development and commercialization of its proprietary AVERT Plus System. Osprey is based out of Exhibition Street, Melbourne, Australia.

Corporate Information

company address Level 13, 41 Exhibition Street, MELBOURNE, VIC, AUSTRALIA, 3000

company phone0410 442 393

company websitehttp://www.ospreymed.com

Dividends

Year-end Date Franking DPS (AUD) Dividend Yield
30/12/2020 -- 0.000 0.00%
30/12/2019 -- 0.000 0.00%
30/12/2018 -- 0.000 0.00%
30/12/2017 -- 0.000 0.00%
30/12/2016 -- 0.000 0.00%
30/12/2015 -- 0.000 0.00%
30/12/2014 -- 0.000 0.00%
30/12/2013 -- 0.000 0.00%
30/12/2012 -- 0.000 0.00%

Event Calendar

Event Type Event Date Event Year
Report (Interim) 2022-08-16 2022
Report (Annual) 2022-03-29 2022
Report (Prelim) 2022-02-25 2022

Financials

Breakdown 30/12/2020 30/12/2019 30/12/2018 30/12/2017 30/12/2016
Trading Revenue 2.171 M 5.231 M 3.562 M 2.091 M 808,651
Other Revenue 20,821 248,258 487,843 141,350 24,575
Total Revenue 2.192 M 5.48 M 4.05 M 2.232 M 833,226
Interest Income 0 0 0 0 0
Interest Expenses 0 0 0 0 0
Expenses -19.163 M -30.87 M -28.478 M -20.354 M -16.866 M
EBITDA -16.971 M -25.39 M -24.428 M -18.122 M -16.033 M
Depreciation and Amortization -391,695 -396,898 -388,104 -253,682 -185,865
Depreciation -375,471 -379,062 -370,399 -237,661 -168,595
Amortisation -16,224 -17,836 -17,704 -16,020 -17,269
EBIT -17.363 M -25.787 M -24.816 M -18.376 M -16.219 M
Pre Tax Profit -17.363 M -25.787 M -24.816 M -18.376 M -16.219 M
Tax Expense -6,851 13,949 -9,890 -4,453 -801
Net Profit After Tax -17.37 M -25.773 M -24.826 M -18.38 M -16.22 M
Minority Interest 0 0 0 0 0
Preference Dividend 0 0 0 0 0
Net Abnormal Items 0 0 0 0 0
Reported Net Profit After Abnormal Items -17.37 M -25.773 M -24.826 M -18.38 M -16.22 M
Ending Shares 16.233 M 2.159 M 2.159 M 3.413 M 2.605 M
Weighted Average Shares 11.833 M 2.159 M 1.774 M 2.865 M 1.907 M
EPS After Abnormal Items (cents) -146.79 -1193.77 -1399.07 -641.57 -850.58
Breakdown 30/12/2020 30/12/2019 30/12/2018 30/12/2017 30/12/2016
Total Current Assets 8.993 M 13.959 M 37.84 M 42.758 M 30.834 M
Total Non Current Assets 1.248 M 1.483 M 1.171 M 1.015 M 922,330
Total Assets 10.242 M 15.442 M 39.011 M 43.773 M 31.756 M
Total Current Liabilities 4.228 M 3.362 M 2.626 M 2.282 M 1.825 M
Total Non Current Liabilities 307,113 548,808 207,232 5,551 29,259
Total Liabilities 4.536 M 3.911 M 2.833 M 2.287 M 1.854 M
Net Assets 5.706 M 11.531 M 36.178 M 41.486 M 29.902 M
Breakdown 30/12/2020 30/12/2019 30/12/2018 30/12/2017 30/12/2016
Net Operating Cash -16.498 M -24.074 M -23.748 M -17.752 M -14.544 M
Net Invested Cash -341,094 -154,842 -437,636 -412,615 -574,849
Net Financing Cash Flows 13.607 M 0 14.433 M 31.345 M 29.033 M
Beginning Cash 10.746 M 36.043 M 45.53 M 28.017 M 16.286 M
End Cash Position 7.514 M 11.814 M 35.778 M 41.199 M 30.201 M
Exchange Rate Adjustments 0 0 0 0 0
Other Cash Adjustments 0 0 0 0 0
Ending Cash 7.514 M 11.814 M 35.778 M 41.199 M 30.201 M

© Morningstar, Inc. 2021. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the market indices, commodities and regulatory news headlines, and other data or content contained herein to be accurate, complete, or timely, and nor shall they have any liability for its use or distribution. The data contained herein: (1) is proprietary to Morningstar and/or its affiliates (collectively, “Morningstar”) and/or their content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Our publications, ratings and products should be viewed as an additional investment resource, and not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your financial situation, contact a professional financial adviser. Some material is copyrighted and published under licence from ASX Operations Pty. Ltd. ACN 004523782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK